θρόμβωσις

The ancient Greek thrombos (θρόμβος) meant a clot of blood, a lump, or a curdled mass — used by Hippocratic physicians who observed that blood drawn from the body thickened and solidified into a coagulated mass. The related verb thrombousthai meant to clot or coagulate, and thrombōsis (θρόμβωσις) named the process. In classical Greek medical thinking, blood that remained inside a living vessel was fluid and vital; blood that clotted did so because it had somehow died or stagnated. This intuition — that clotting within a living vessel was pathological — was remarkably prescient, even if the mechanism was opaque for two millennia.

For most of medical history, thrombosis was an autopsy finding rather than a clinical diagnosis. Physicians dissecting bodies found clots within veins and arteries, but the relationship between intravascular clotting and clinical death was unclear. It was Rudolf Virchow, once again, who in the 1850s systematically articulated this relationship — demonstrating that clots forming in the deep veins of the legs could propagate and detach (embolism), or could organize and occlude the vessel (thrombosis). Virchow distinguished the ante-mortem clot (formed in the living body) from the post-mortem clot (formed after death) by its structure and attachment to the vessel wall. This distinction was clinically critical: the ante-mortem clot caused disease; the post-mortem clot merely documented it.

The 20th century revealed the molecular machinery of thrombosis: platelets, coagulation factors, fibrin, and the competing fibrinolytic system that dissolves clots. The discovery of heparin by Jay McLean in 1916 and its clinical development by Charles Best (co-discoverer of insulin) provided the first anticoagulant drug. Warfarin followed in the 1950s, and the direct oral anticoagulants (rivaroxaban, apixaban, dabigatran) arrived in the 2000s. Coronary thrombosis — the formation of a clot on an atherosclerotic plaque in a coronary artery, causing myocardial infarction (heart attack) — became understood as the proximate cause of most acute cardiac deaths, and antiplatelet drugs (aspirin, clopidogrel) were developed to prevent it.

Coronary artery thrombosis causes approximately 7 million deaths per year worldwide, making it the single leading cause of death globally. Cerebral artery thrombosis causes stroke, the second leading cause of death. Deep vein thrombosis and pulmonary embolism are the third most common acute cardiovascular cause of death. The Greek word for a clump of blood now names the pathological mechanism behind the three most common causes of cardiovascular death. The Hippocratic observation that blood could solidify abnormally within a living vessel was not just descriptively accurate — it named the mechanism of the leading killer in the modern world.